Drug profile · INN
cilastatin sodium
IMIPENEM AND CILASTATIN
cilastatin sodium (IMIPENEM AND CILASTATIN) is a renal dipeptidase inhibitor. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — cilastatin sodium
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
cilastatin sodium (IMIPENEM AND CILASTATIN) is a renal dipeptidase inhibitor. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Renal dipeptidase inhibitor
Primary target: Dipeptidase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is cilastatin sodium?
cilastatin sodium (IMIPENEM AND CILASTATIN) is a renal dipeptidase inhibitor. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for cilastatin sodium?
IMIPENEM AND CILASTATIN is a marketed brand name for cilastatin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cilastatin sodium?
cilastatin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.